Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 4
2000 2
2001 4
2002 1
2003 1
2004 3
2008 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacogenetics of human androgens and prostate cancer--an update.
Novelli G, Margiotti K, Chiocca AM, Spera E, Micali F, Reichardt JK. Novelli G, et al. Pharmacogenomics. 2004 Apr;5(3):283-94. doi: 10.1517/phgs. Pharmacogenomics. 2004. PMID: 15102543 Review.
Molecular epidemiology of hormone-metabolic loci in prostate cancer.
Makridakis NM, Reichardt JK. Makridakis NM, et al. Epidemiol Rev. 2001;23(1):24-9. doi: 10.1093/oxfordjournals.epirev.a000791. Epidemiol Rev. 2001. PMID: 11588850 Review. No abstract available.
Pharmacogenetics of human androgens and prostatic diseases.
Novelli G, Margiotti K, Sangiuolo F, Reichardt JK. Novelli G, et al. Pharmacogenomics. 2001 Feb;2(1):65-72. doi: 10.1517/14622416.2.1.65. Pharmacogenomics. 2001. PMID: 11258198 Review.
A renaissance of "biochemical genetics"? SNPs, haplotypes, function, and complex diseases.
Mehrian-Shai R, Reichardt JK. Mehrian-Shai R, et al. Mol Genet Metab. 2004 Sep-Oct;83(1-2):47-50. doi: 10.1016/j.ymgme.2004.07.014. Mol Genet Metab. 2004. PMID: 15464419 Review.
Genetic susceptibility to cancer from exogenous and endogenous exposures.
Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. J Cell Biochem Suppl. 1996;25:15-22. doi: 10.1002/(sici)1097-4644(1996)25+<15::aid-jcb2>;2-5. J Cell Biochem Suppl. 1996. PMID: 9027593 Review.
GEN GEN: the genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes.
Reichardt JK. Reichardt JK. Front Biosci. 1999 Jul 15;4:D596-600. doi: 10.2741/reichardt. Front Biosci. 1999. PMID: 10417059 Review.
Multiplex automated primer extension analysis: simultaneous genotyping of several polymorphisms.
Makridakis NM, Reichardt JK. Makridakis NM, et al. Biotechniques. 2001 Dec;31(6):1374-80. doi: 10.2144/01316md05. Biotechniques. 2001. PMID: 11768667 Free article.
Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men.
Allen NE, Reichardt JK, Nguyen H, Key TJ. Allen NE, et al. Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):578-81. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12815006 Free article.
Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.
Pearce CL, Makridakis NM, Ross RK, Pike MC, Kolonel LN, Henderson BE, Reichardt JK. Pearce CL, et al. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):417-8. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927504 Free article. No abstract available.
Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
Makridakis NM, di Salle E, Reichardt JK. Makridakis NM, et al. Pharmacogenetics. 2000 Jul;10(5):407-13. doi: 10.1097/00008571-200007000-00004. Pharmacogenetics. 2000. PMID: 10898110
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page